Patents Assigned to New Frontier Labs, LLC
  • Azelaic acid esters in the treatment of insulin resistance
    Patent number: 10251857
    Abstract: A method of treating insulin resistance includes administering to a subject a pharmaceutical composition comprising diethyl azelate. For example, a method of treating insulin resistance includes orally administering to a subject a pharmaceutical composition that includes diethyl azelate at a dosage range from about 0.1 mg/kg/day to about 10 mg/kg/day.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: April 9, 2019
    Assignee: New Frontier Labs, LLC
    Inventors: Robert T. Streeper, Elzbieta Izbicka